Effect of a single vaginal administration of levonorgestrel in Carraguard® gel on the ovulatory process: A potential candidate for "dual protection" emergency contraception
Document Type
Article (peer-reviewed)
Publication Date
2007
Abstract
Objective: The study was conducted to evaluate the effect of Carraguard vaginal gel containing 0.75 mg of levonorgestrel (CARRA/LNG gel) administered in a single dose at different stages of follicle development over subsequent follicle rupture and hormonal levels. Method: Randomized, blinded, cross-over study comparing the effects of a single administration of CARRA/LNG gel or Carraguard (CARRA) gel. Twenty-four healthy women were enrolled in two centers. The gels were administered when the follicle had reached diameters of 12-14, 15-17 and ≥18 mm in eight women each. Volunteers were followed for one treatment, one washout cycle and a second treatment cycle. Follicle rupture or nonrupture was assessed by transvaginal ultrasound. Luteinizing hormone, estradiol and progesterone levels were measured daily for 5 days following treatment, and three times per week until menses. Results: No follicular rupture within the 5-day period following administration was observed in 74% and 30% of the CARRA/LNG and CARRA gel treatment cycles, respectively, while ovulation was documented in 4% and 61%, respectively. The overall proportion of cycles with lack of follicular rupture or ovulatory dysfunction (follicle rupture preceded by an inadequate LH surge) was 96% for CARRA/LNG and 39% in the CARRA gel cycles. Conclusion: Single vaginal administration of 0.75 mg LNG in CARRA gel in the late follicular phase is effective for interfering with the ovulatory process.
Recommended Citation
Brache, Vivian, Horacio B. Croxatto, Régine Sitruk-Ware, Robin A. Maguire, Juan Carlos Montero, Narender Kumar, Ana Maria Salvatierra, Ana-Sofia Tejada, Leila Cochon, Maria Luisa Forcelledo, Pekka Lahteenmaki, Francisco Alvarez, and Anibal Faundes. 2007. "Effect of a single vaginal administration of levonorgestrel in Carraguard® gel on the ovulatory process: A potential candidate for dual protection emergency contraception," Contraception 76(2): 111–116.
DOI
10.1016/j.contraception.2007.04.005
Language
English
https://doi.org/10.1016/j.contraception.2007.04.005